Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of in Vivo Percutaneous Cryobiopsy from the Human Bile Duct - CRYLEO

NCT06249841 is registered in ClinicalTrials.gov with Erbe Elektromedizin GmbH as lead sponsor.

NCT NCT06249841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06249841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of in Vivo Percutaneous Cryobiopsy from the Human Bile Duct - CRYLEO
Lead sponsor
Erbe Elektromedizin GmbH
Phase
Not applicable
Overall status
Completed
Start date
March 4, 2024
Completion date
August 30, 2024
Enrollment
15 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms, bile duct